00660 瑋俊生物科技
公司資料 - 損益表
瑋俊生物科技有限公司 股票編號: 00660
WAI CHUN BIO-TECHNOLOGY LIMITED 集團網址: http://www.0660.hk
2024/06 - 末期
港元($)
變動 2023/06
港元($)
2022/06
港元($)
2020/12
港元($)
2019/12
港元($)
營業額 / 收益370,069,000-52.166%773,654,0001,007,186,000567,553,000579,231,000
銷售成本(335,888,000)-53.558%(723,241,000)(917,001,000)(518,623,000)(530,204,000)
毛利34,181,000-32.198%50,413,00090,185,00048,930,00049,027,000
 
投資物業公平值變動及減值------------
其他項目公平值變動及減值(58,149,000)--------(2,282,000)
出售項目溢利 / (虧損)----------67,000
其他非經營項目------------
分佔聯營公司及共同控制公司業績0--0000
除稅前溢利 / (虧損)(78,167,000)1271.832%(5,698,000)3,777,0001,611,0009,063,000
稅項12,460,000--(4,364,000)(5,167,000)(616,000)(75,000)
已終止經營業務溢利 / (虧損)------------
非控股權益21,495,000--(5,371,000)(20,155,000)(9,144,000)(12,147,000)
其他項目------------
股東應佔溢利 / (虧損)(44,212,000)186.477%(15,433,000)(21,545,000)(8,149,000)(3,159,000)
 
淨財務支出 / (收入)17,897,0004.808%17,076,00020,924,0007,889,0005,816,000
折舊及攤銷11,359,000-19.222%14,062,00016,198,0006,375,0005,333,000
董事酬金----1,549,0004,737,0002,760,0001,719,000
 
核數師意見無保留意見 (修定報告)--無保留意見 (修定報告)無保留意見 (修定報告)無保留意見 (修定報告)無保留意見 (修定報告)
 
市場價值指標
每股盈利 (仙)-25.800---9.100-12.900-4.900-1.900
每股派息 (仙)0.000--0.0000.0000.0000.000
派息比率 (%)------------
每股現金流 ($)----0.2900.029-0.0020.009
每股帳面資產淨值 ($)-0.462---0.204-0.224-0.226-0.303
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.